(Q39407202)

11 September 2017

title

Frovatriptan for the acute treatment of migraine: a dose-finding study (English)

1 reference

11 September 2017

1 reference

Jerome Goldstein

1 reference

11 September 2017

C Keywood

series ordinal

1 reference

11 September 2017

251/96/14 Study Group

series ordinal

1 reference

11 September 2017

publication date

1 January 2002

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

41-48

1 reference

Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Transmural myocardial infarction with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

Cardiorespiratory distress after sumatriptan given by injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02012.X

10.1046/J.1526-4610.2002.02012.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference